NATALIE STROUD: Open Payments
NPI 1003393174 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 17 payments from 15 companies in 2025. Trend: 2023 $827 · 2024 $657 · 2025 $791
Food & beverage: $791
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $132 |
| Madrigal Pharmaceuticals | 1 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $100 |
| Viatris Specialty LLC | 1 | $79 |
| Amgen Inc. | 2 | $39 |
| SHIELD THERAPEUTICS INC | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
Products named: ULTOMIRIS, REZDIFFRA, Wegovy, NEFFY, YUPELRI, ACCRUFER, Kerendia, REPATHA.
Industry payments across NC — which companies pay providers there.
